Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Raymond Rackley, MD, is Professor of Surgery at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and Staff in the Center for Pelvic Health and Reconstructive Surgery within the Glickman Urological and Kidney Institute. Dr. Rackley earned his biomedical engineering degree from Duke University and his medical degree from Case Western Reserve University. He completed a urology residency as well as fellowship training in voiding dysfunction and female urology at Cleveland Clinic. He currently holds Staff appointments in the Glickman Urological and Kidney Institute, the Department of Obstetrics and Gynecology, and the Lerner Research Institute as Director of the basic science Urothelial Biology Laboratory.
Dr. Rackley’s primary focus is on the clinical care of people with pelvic health disorders and the education of those who serve to improve pelvic health. In addition to his full-time clinical responsibilities, he actively manages an NIH and extramurally funded research laboratory for reconstructive and basic science investigations of the lower urinary tract.
During his leadership tenure within the Center of Pelvic Health and Reconstructive Surgery, the Center has evolved as one of the premier centers for national and international educational forums for residents, fellows and postgraduate physicians pursuing expansion of their basic science and clinical knowledge supporting their practices in pelvic health. Dr. Rackley’s programmatic developments for the Center includes formal preceptorships and CME courses held annually for urology residents, fellows and postgraduate urologists, as well as guest preceptorships in clinical practice development and surgical training in pelvic health. He enjoys formal and informal didactic, as well as live, surgical telecast training forums of traditional and minimally invasive procedures such as laparoscopic approaches to pelvic reconstruction.
Dr. Rackley serves as the Principal Investigator and Co-Principal Investigator on NIH grants, as well as other extramural foundation and society grants that focus on bladder health and pelvic organ reconstructive developments. He has also authored or co-authored more than 100 peer-reviewed publications in clinical and basic science topics in pelvic health and urology including numerous chapters in the leading textbooks on urology and pelvic reconstructive surgery. He serves as a reviewer for the leading peer-reviewed national and international urology and gynecology journals, grant reviewer for foundations such as the National Kidney Foundation, and a committee member for the Data and Safety Monitoring Board for the NIH Clinical Research Trials Network for Interstitial Cystitis and Chronic Pelvic Pain and the Bladder Advisory Council of the AUA Foundation. He was recently elected to the Executive Board of the Society of Female Urology and Urodynamics.
Complex or previously failed incontinence conditions including males; Interstitial cystitis;
Laparoscopic and robotic female prolapse and reconstructive surgery; Neuromodulation for bladder and bowel dysfunction;
Regenerative and stem cell based therapies for incontinence, prolapse, and interstitial cystitis;
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 11/24/2014, Dr. Rackley has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.